Scarica l'app Stockscreener
85.85
2.00%
1.68
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EW Giù?
Forum
Previsione
Frazionamento azionario
Edwards Lifesciences Corp Borsa (EW) Ultime notizie
Donald Bobo Jr Sells 11,340 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Edwards Lifesciences (NYSE:EW) Will Want To Turn Around Its Return Trends - simplywall.st
Econ Financial Services Corp Acquires 15,836 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Ninety One UK Ltd Buys 969,030 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Ninety One North America Inc. Acquires 71,017 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Short Interest Down 19.2% in December - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Purchases 56,000 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Cwm LLC Purchases 43,065 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) Shares Unloaded Rep. Josh Gottheimer - MarketBeat
Mirova US LLC Has $219.47 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Farmers & Merchants Investments Inc. Sells 15,037 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Stifel Upgrades Edwards Lifesciences (EW) - MSN
Edwards Lifesciences Corp Stock Price Live, Charts & News - The Economic Times
Edwards Sapien M3 Valve Gets FDA Approval - Orange County Business Journal
World Investment Advisors Has $2.81 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Litman Gregory Wealth Management LLC - MarketBeat
Edwards Lifesciences Corp (EW) Stock Price History & Data - Traders Union
Covea Finance Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
How Do Investors Really Feel About Edwards Lifesciences Corp? - Sahm
Transcatheter Mitral Valve Replacement System Receives FDA Clearance - Diagnostic and Interventional Cardiology
HALPER SADEH LLC ENCOURAGES EDWARDS LIFESCIENCES CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - Finviz
Edwards Lifesciences Corp (EW) Stock Price, Trades & News - GuruFocus
Edwards Lifesciences Corporation $EW Shares Sold by OLD National Bancorp IN - MarketBeat
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy - BioSpace
Edwards Lifesciences (EW): Assessing Valuation After Recent Share Price Strength - Yahoo Finance
EW SEC FilingsEdwards Lifesciences Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Edwards lands first FDA approval for transcatheter MVR - BioWorld MedTech
The Zacks Analyst Blog Highlights Cardinal Health, Medtronic, Intuitive Surgical and Edwards Lifesciences - Yahoo Finance
Edwards Lifesciences Says FDA Approves Valve Replacement System - marketscreener.com
Edwards wins FDA approval for Sapien M3 mitral valve, marking first transseptal transcatheter therapy - MassDevice
Edwards Lifesciences’ SAPIEN M3 becomes first FDA-approved mitral valve system - Investing.com
Edwards Lifesciences gets FDA approval for SAPIEN M3 mitral valve system By Investing.com - Investing.com South Africa
Edwards Lifesciences gets FDA approval for SAPIEN M3 mitral valve system - Investing.com Canada
FDA approves Edwards Lifesciences' Sapien M3 mitral valve replacement system as first transseptal transcatheter therapy - marketscreener.com
FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy – Company AnnouncementFT.com - Financial Times
OFI Invest Asset Management Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Legacy Wealth Asset Management LLC - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences Advances Smart Surgery Monitoring With Completed SMART TRENDS Study - TipRanks
Seilern Investment Management Ltd Sells 183,101 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
How JP Morgan’s Upgrade and 2026 Conference Spotlight Will Impact Edwards Lifesciences (EW) Investors - simplywall.st
Edwards Lifesciences (BSP:E1WL34) EV-to-OCF : 46.58 (As of Dec. 20, 2025) - GuruFocus
Edwards Lifesciences Corporation $EW Shares Sold by Texas Permanent School Fund Corp - MarketBeat
Profit Review: How Edwards Lifesciences Corporation stock compares to industry benchmarksPrice Action & Capital Efficiency Focused Ideas - Улправда
Edwards Lifesciences Corporation (EW) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
How Edwards Lifesciences Corporation stock performs in rate cut cyclesJuly 2025 Setups & Daily Profit Focused Stock Screening - Улправда
What makes Edwards Lifesciences Corporation stock attractive to growth fundsJuly 2025 Opening Moves & Community Verified Trade Alerts - ulpravda.ru
Edwards Lifesciences (WBO:EWLS) EV-to-OCF : 44.69 (As of Dec. 19, 2025) - GuruFocus
Edwards Lifesciences (NYSE:EW) Updates FY 2025 Earnings Guidance - MarketBeat
Amiral Gestion Has $21.99 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
How Edwards Lifesciences Corporation stock compares to industry benchmarks - ulpravda.ru
JP Morgan Upgrades Edwards Lifesciences (EW) Rating to Overweigh - GuruFocus
Edwards Lifesciences (NYSE:EW) Shares Little Changed in NYSE Session - Kalkine Media
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace
Orser Capital Management LLC Acquires Shares of 27,953 Edwards Lifesciences Corporation $EW - MarketBeat
JPMorgan Upgrades Edwards Lifesciences to Overweight From Neutral, Adjusts PT to $100 From $90 - marketscreener.com
JPMorgan upgrades Edwards Lifesciences stock rating to Overweight - Investing.com
Canaccord Genuity Lowers Price Target for Edwards Lifesciences (EW) to $87 | EW Stock News - GuruFocus
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider - GlobeNewswire Inc.
Assenagon Asset Management S.A. Has $127.34 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Reassessing Valuation After Strong Sales Growth and Upgraded Guidance - simplywall.st
1.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):